BR0114310A - Derivados do glicopiranosiloxibenzilbenzeno e composições medicinais contendo os mesmos - Google Patents

Derivados do glicopiranosiloxibenzilbenzeno e composições medicinais contendo os mesmos

Info

Publication number
BR0114310A
BR0114310A BR0114310-7A BR0114310A BR0114310A BR 0114310 A BR0114310 A BR 0114310A BR 0114310 A BR0114310 A BR 0114310A BR 0114310 A BR0114310 A BR 0114310A
Authority
BR
Brazil
Prior art keywords
lower alkoxy
derivatives
glycopyranosyloxybenzylbenzene
compositions containing
medicinal compositions
Prior art date
Application number
BR0114310-7A
Other languages
English (en)
Inventor
Hideki Fujikura
Nobuhiko Fushimi
Toshihiro Nishimura
Kazuya Tatani
Masayuki Isaji
Original Assignee
Kissei Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kissei Pharmaceutical filed Critical Kissei Pharmaceutical
Publication of BR0114310A publication Critical patent/BR0114310A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/203—Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

"DERIVADOS DO GLICOPIRANOSILOXIBENZILBENZENO E COMPOSIçõES MEDICINAIS CONTENDO OS MESMOS". Derivados do glicopiranosiloxibenzilbenzeno representados pela seguinte fórmula geral (I) que possuem uma capacidade de absorção oral melhorada, exercem um efeito excelente de inibição da atividade do SGLT2 humano in vivo e, dessa forma, são úteis como preventivos ou medicamentos para doenças causadas por hiperglicemia tais como diabetes, complicações diabéticas e obesidade onde P representa um grupo que constitui uma pró-droga; e R representa alquila inferior, alcóxi inferior, alquiltio inferior, alcóxi inferior, alquila inferior, alcóxi inferior, alcóxi inferior ou alcóxi inferior, alquiltio inferior.
BR0114310-7A 2000-09-29 2001-09-21 Derivados do glicopiranosiloxibenzilbenzeno e composições medicinais contendo os mesmos BR0114310A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000301523 2000-09-29
PCT/JP2001/008239 WO2002028872A1 (fr) 2000-09-29 2001-09-21 Derives de glucopyranosiloxybenzylbenzene et compositions therapeutiques contenant ces composes

Publications (1)

Publication Number Publication Date
BR0114310A true BR0114310A (pt) 2003-10-14

Family

ID=18783054

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0114310-7A BR0114310A (pt) 2000-09-29 2001-09-21 Derivados do glicopiranosiloxibenzilbenzeno e composições medicinais contendo os mesmos

Country Status (33)

Country Link
US (2) US6872706B2 (pt)
EP (1) EP1329456B1 (pt)
JP (1) JP3798375B2 (pt)
KR (1) KR100647204B1 (pt)
CN (1) CN1293087C (pt)
AR (1) AR030816A1 (pt)
AT (1) ATE335753T1 (pt)
AU (2) AU9025701A (pt)
BG (1) BG66015B1 (pt)
BR (1) BR0114310A (pt)
CA (1) CA2423568C (pt)
CY (1) CY1106076T1 (pt)
CZ (1) CZ303544B6 (pt)
DE (1) DE60122193T2 (pt)
DK (1) DK1329456T3 (pt)
EA (1) EA005994B1 (pt)
ES (1) ES2269456T3 (pt)
HK (1) HK1061037A1 (pt)
HU (1) HUP0301178A3 (pt)
IL (2) IL155071A0 (pt)
MX (1) MXPA03002779A (pt)
MY (1) MY129023A (pt)
NO (1) NO327182B1 (pt)
NZ (1) NZ524917A (pt)
PE (1) PE20020476A1 (pt)
PL (1) PL205607B1 (pt)
PT (1) PT1329456E (pt)
SI (1) SI1329456T1 (pt)
SK (1) SK287811B6 (pt)
TW (1) TWI284641B (pt)
UA (1) UA73606C2 (pt)
WO (1) WO2002028872A1 (pt)
ZA (1) ZA200302283B (pt)

Families Citing this family (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1020944C (zh) 1990-01-30 1993-05-26 阿图尔-费希尔股份公司费希尔厂 紧固件
IL155071A0 (en) 2000-09-29 2003-10-31 Kissei Pharmaceutical Glucopyranosyloxybenzylbenzene derivatives and medical compositions containing the same
CA2429833A1 (en) * 2000-11-30 2002-06-06 Kissei Pharmaceutical Co., Ltd. Glucopyranosyloxybenzylbenzene derivatives, medicinal compositions containing the same and intermediates in the production thereof
TWI255817B (en) 2001-02-14 2006-06-01 Kissei Pharmaceutical Glucopyranosyloxybenzylbenzene derivatives and medicinal use thereof
MXPA04009229A (es) * 2002-03-22 2004-11-26 Kissei Pharmaceutical Cristales derivados de glucopiranosiloxibencil benceno.
BR0310006A (pt) * 2002-08-09 2005-02-15 Taisho Pharmaceutical Co Ltd Derivados de 5-tio-beta-d-glicopiranosìdeo de arila e agentes terapêuticos para diabetes contendo os mesmos
JP4651934B2 (ja) * 2002-12-04 2011-03-16 キッセイ薬品工業株式会社 ベンジルフェノール誘導体、それを含有する医薬組成物およびその医薬用途
CA2507665A1 (en) * 2002-12-04 2004-06-17 Kissei Pharmaceutical Co., Ltd. Preventive or remedy for diseases caused by hyperglycemia
DE10258008B4 (de) * 2002-12-12 2006-02-02 Sanofi-Aventis Deutschland Gmbh Heterocyclische Fluorglycosidderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zur Herstellung dieser Arzneimittel
DE10258007B4 (de) 2002-12-12 2006-02-09 Sanofi-Aventis Deutschland Gmbh Aromatische Fluorglycosidderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zur Herstellung dieser Arzneimittel
UA86042C2 (en) * 2003-08-01 2009-03-25 Янссен Фармацевтика Н.В. Substituted indazole-o-glucosides
EP2295422A3 (de) 2004-03-16 2012-01-04 Boehringer Ingelheim International GmbH Glucopyranosylsubstituierte Benzolderivate, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung
WO2005095429A1 (ja) * 2004-03-31 2005-10-13 Kissei Pharmaceutical Co., Ltd. フェノール誘導体、それを含有する医薬組成物及びその医薬用途
CA2572793C (en) 2004-07-21 2015-11-03 Kissei Pharmaceutical Co., Ltd. Progression inhibitor for disease attributed to abnormal accumulation of liver fat
TW200606129A (en) 2004-07-26 2006-02-16 Chugai Pharmaceutical Co Ltd Novel cyclohexane derivative, its prodrug, its salt and diabetic therapeutic agent containing the same
EP1828216B1 (en) * 2004-12-16 2008-09-10 Boehringer Ingelheim International GmbH Glucopyranosyl-substituted benzene derivatives, medicaments containing such compounds, their use and process for their manufacture
TW200637869A (en) 2005-01-28 2006-11-01 Chugai Pharmaceutical Co Ltd The spiroketal derivatives and the use as therapeutical agent for diabetes of the same
JP5073948B2 (ja) * 2005-01-31 2012-11-14 田辺三菱製薬株式会社 医薬組成物
ES2334940T3 (es) * 2005-02-23 2010-03-17 Boehringer Ingelheim International Gmbh Derivados de ((hetero)ariletinilbencil)benceno sustituidos con glucopiranosilo y uso de los mismos como inhibidores del cotransportador 2 de glucosa dependiente de sodio (sglt2).
EP1874787B1 (en) * 2005-04-15 2009-12-30 Boehringer Ingelheim International GmbH Glucopyranosyl-substituted (heteroaryloxy-benzyl)-benzene derivatives as sglt inhibitors
US7723309B2 (en) * 2005-05-03 2010-05-25 Boehringer Ingelheim International Gmbh Crystalline forms of 1-chloro-4-(β-D-glucopyranos-1-yl)-2-[4-((R)-tetrahydrofuran-3-yloxy)-benzyl]-benzene, a method for its preparation and the use thereof for preparing medicaments
UA91546C2 (uk) * 2005-05-03 2010-08-10 Бьорінгер Інгельхайм Інтернаціональ Гмбх КРИСТАЛІЧНА ФОРМА 1-ХЛОР-4-(β-D-ГЛЮКОПІРАНОЗ-1-ИЛ)-2-[4-((S)-ТЕТРАГІДРОФУРАН-3-ІЛОКСИ)-БЕНЗИЛ]-БЕНЗОЛУ, СПОСІБ ЇЇ ОДЕРЖАННЯ ТА ЇЇ ЗАСТОСУВАННЯ ПРИ ПРИГОТУВАННІ ЛІКАРСЬКИХ ЗАСОБІВ
US7772191B2 (en) * 2005-05-10 2010-08-10 Boehringer Ingelheim International Gmbh Processes for preparing of glucopyranosyl-substituted benzyl-benzene derivatives and intermediates therein
WO2007014894A2 (en) * 2005-07-27 2007-02-08 Boehringer Ingelheim International Gmbh Glucopyranosyl-substituted ( (hetero) cycloalyklethynyl-benzyl) -benzene derivatives and use thereof as sodium-dependent glucose cotransporter (sglt) inhibitors
CA2620566A1 (en) * 2005-08-30 2007-03-08 Boehringer Ingelheim International Gmbh Glucopyranosyl-substituted benzyl-benzene derivatives, medicaments containing such compounds, their use and process for their manufacture
ATE491700T1 (de) * 2005-09-08 2011-01-15 Boehringer Ingelheim Int KRISTALLINE FORMEN VON 1-CHLORO-4-(ß-D-
AR056195A1 (es) * 2005-09-15 2007-09-26 Boehringer Ingelheim Int Procedimientos para preparar derivados de (etinil-bencil)-benceno sustituidos de glucopiranosilo y compuestos intermedios de los mismos
CA2635838A1 (en) * 2006-02-15 2007-08-23 Boehringer Ingelheim International Gmbh Glucopyranosyl-substituted benzonitrile derivatives, pharmaceutical compositions containing such compounds, their use and process for their manufacture
PE20080697A1 (es) * 2006-05-03 2008-08-05 Boehringer Ingelheim Int Derivados de benzonitrilo sustituidos con glucopiranosilo, composiciones farmaceuticas que contienen compuestos de este tipo, su uso y procedimiento para su fabricacion
PE20080251A1 (es) 2006-05-04 2008-04-25 Boehringer Ingelheim Int Usos de inhibidores de dpp iv
DE102006028862A1 (de) 2006-06-23 2007-12-27 Merck Patent Gmbh 3-Amino-imidazo[1,2-a]pyridinderivate
TW200817424A (en) 2006-08-04 2008-04-16 Daiichi Sankyo Co Ltd Benzylphenyl glucopyranoside derivatives
US20080109178A1 (en) * 2006-11-03 2008-05-08 Nikon Corporation Method and system for predicting and correcting signal fluctuations of an interferometric measuring apparatus
ES2374952T3 (es) 2006-12-06 2012-02-23 Glaxosmithkline Llc Compuestos bicíclicos y uso como antidiabéticos.
DE102007008420A1 (de) 2007-02-21 2008-08-28 Merck Patent Gmbh Benzimidazolderivate
CL2008002427A1 (es) * 2007-08-16 2009-09-11 Boehringer Ingelheim Int Composicion farmaceutica que comprende 1-cloro-4-(b-d-glucopiranos-1-il)-2-[4-((s)-tetrahidrofurano-3-iloxi)bencil]-benceno combinado con 1-[(4-metilquinazolin-2-il)metil]-3-metil-7-(2-butin-1-il)-8-(3-(r)-aminopiperidin-1-il)xantina; y su uso para tratar diabetes mellitus tipo 2.
DE102007048716A1 (de) 2007-10-11 2009-04-23 Merck Patent Gmbh Imidazo[1,2-a]pyrimidinderivate
CL2008003653A1 (es) 2008-01-17 2010-03-05 Mitsubishi Tanabe Pharma Corp Uso de un inhibidor de sglt derivado de glucopiranosilo y un inhibidor de dppiv seleccionado para tratar la diabetes; y composicion farmaceutica.
WO2009096503A1 (ja) * 2008-01-31 2009-08-06 Daiichi Sankyo Company, Limited ベンジルフェニルグルコピラノシド誘導体
DE102008017590A1 (de) 2008-04-07 2009-10-08 Merck Patent Gmbh Glucopyranosidderivate
BRPI0916769A2 (pt) 2008-07-15 2017-09-26 Theracos Inc derivados de benzilbenzeno deuterados e métodos de uso
EA018492B1 (ru) * 2008-08-28 2013-08-30 Пфайзер Инк. Диоксабицикло[3.2.1]октан-2,3,4-триольные производные
KR101921934B1 (ko) * 2009-02-13 2018-11-26 베링거 인겔하임 인터내셔날 게엠베하 글루코피라노실 디페닐메탄 유도체를 포함하는 약제학적 조성물, 이들의 약제학적 용량형, 이들의 제조방법 및 환자에서의 개선된 당 조절을 위한 이들의 용도
CN104906582A (zh) 2009-02-13 2015-09-16 勃林格殷格翰国际有限公司 包含sglt2抑制剂、dpp-iv抑制剂和任选的另一种抗糖尿病药的药物组合物及其用途
CA2775961C (en) * 2009-09-30 2017-11-07 Boehringer Ingelheim International Gmbh Method for the preparation of a crystalline form of 1-chloro-4-(beta-d-glucopyranos-1-yl)-2-(4-((s)-tetrahydrofuran-3-yloxy)benzyl)benzene
EP2486029B1 (en) 2009-09-30 2015-06-10 Boehringer Ingelheim International GmbH Processes for preparing of glucopyranosyl-substituted benzyl-benzene derivatives
UY32919A (es) * 2009-10-02 2011-04-29 Boehringer Ingelheim Int Composición farmacéutica, forma de dosificación farmacéutica, procedimiento para su preparación, mé todos para su tratamiento y sus usos
US8163704B2 (en) 2009-10-20 2012-04-24 Novartis Ag Glycoside derivatives and uses thereof
AU2010309788A1 (en) 2009-10-20 2012-04-05 Novartis Ag Glycoside derivative and uses thereof
JP5696156B2 (ja) 2009-11-02 2015-04-08 ファイザー・インク ジオキサ−ビシクロ［３．２．１］オクタン−２，３，４−トリオール誘導体
AR079438A1 (es) 2009-12-09 2012-01-25 Panacea Biotec Ltd Derivados de azucar, composiciones farmaceuticas y sus usos
WO2011107494A1 (de) 2010-03-03 2011-09-09 Sanofi Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung
WO2012025857A1 (en) 2010-08-23 2012-03-01 Hetero Research Foundation Cycloalkyl methoxybenzyl phenyl pyran derivatives as sodium dependent glucose co transporter (sglt2) inhibitors
AR085689A1 (es) 2011-03-07 2013-10-23 Boehringer Ingelheim Int Composiciones farmaceuticas de metformina, linagliptina y un inhibidor de sglt-2
BR112013026361A2 (pt) 2011-04-14 2016-12-27 Novartis Ag derivados de glicosídeo e usos dos mesmos
US8614195B2 (en) 2011-04-14 2013-12-24 Novartis Ag Glycoside derivatives and uses thereof
US9555001B2 (en) 2012-03-07 2017-01-31 Boehringer Ingelheim International Gmbh Pharmaceutical composition and uses thereof
US9192617B2 (en) 2012-03-20 2015-11-24 Boehringer Ingelheim International Gmbh Pharmaceutical composition, methods for treating and uses thereof
EP2774619B1 (de) 2013-03-04 2016-05-18 BioActive Food GmbH Zusammensetzung zur Behandlung von hyperglykämischen Erkrankungen
BR112015022441B1 (pt) 2013-03-14 2021-12-07 Mars, Incorporated Composição de sabor que contém glicosídeos de hmg
TR201901110T4 (tr) 2013-04-05 2019-02-21 Boehringer Ingelheim Int Empagliflozinin terapötik kullanımları.
US20140303097A1 (en) 2013-04-05 2014-10-09 Boehringer Ingelheim International Gmbh Pharmaceutical composition, methods for treating and uses thereof
US11813275B2 (en) 2013-04-05 2023-11-14 Boehringer Ingelheim International Gmbh Pharmaceutical composition, methods for treating and uses thereof
SI2986304T1 (sl) 2013-04-18 2022-04-29 Boehringer Ingelheim International Gmbh Farmacevtski sestavek, postopki za zdravljenje in njegove uporabe
EP2944311A1 (de) 2014-05-16 2015-11-18 BioActive Food GmbH Kombination von biologisch aktiven Substanzen zur Behandlung von hyperglykämischen Erkrankungen

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2549476B1 (fr) 1983-07-20 1986-04-25 Rech Ind Benzyl-phenyl-osides, procede de preparation et utilisation en therapeutique
CA2102591C (en) 1992-11-12 2000-12-26 Kenji Tsujihara Hypoglycemic agent
US5731292A (en) * 1992-11-12 1998-03-24 Tanabe Seiyaku Co., Ltd. Dihydrochalcone derivatives which are hypoglycemic agents
RU2254340C2 (ru) * 2000-03-17 2005-06-20 Киссеи Фармасьютикал Ко., Лтд. Глюкопиранозилоксибензилбензольные производные, лекарственные композиции, содержащие эти производные, и промежуточные соединения для получения указанных производных
US6683056B2 (en) * 2000-03-30 2004-01-27 Bristol-Myers Squibb Company O-aryl glucoside SGLT2 inhibitors and method
IL155071A0 (en) 2000-09-29 2003-10-31 Kissei Pharmaceutical Glucopyranosyloxybenzylbenzene derivatives and medical compositions containing the same

Also Published As

Publication number Publication date
KR100647204B1 (ko) 2006-11-17
CN1293087C (zh) 2007-01-03
BG107674A (bg) 2004-01-30
CZ303544B6 (cs) 2012-11-28
PE20020476A1 (es) 2002-07-04
HK1061037A1 (en) 2004-09-03
PL205607B1 (pl) 2010-05-31
SK3342003A3 (en) 2003-08-05
NO327182B1 (no) 2009-05-04
US6872706B2 (en) 2005-03-29
ES2269456T3 (es) 2007-04-01
DE60122193T2 (de) 2007-07-05
US20050065098A1 (en) 2005-03-24
EA005994B1 (ru) 2005-08-25
WO2002028872A1 (fr) 2002-04-11
DE60122193D1 (de) 2006-09-21
HUP0301178A3 (en) 2009-08-28
EP1329456A1 (en) 2003-07-23
NO20031407D0 (no) 2003-03-27
EA200300316A1 (ru) 2003-08-28
AU9025701A (en) 2002-04-15
AU2001290257B2 (en) 2007-08-30
KR20030036867A (ko) 2003-05-09
PT1329456E (pt) 2006-12-29
CY1106076T1 (el) 2011-06-08
NO20031407L (no) 2003-04-30
JP3798375B2 (ja) 2006-07-19
TWI284641B (en) 2007-08-01
IL155071A0 (en) 2003-10-31
ZA200302283B (en) 2005-05-27
EP1329456A4 (en) 2005-03-30
EP1329456B1 (en) 2006-08-09
NZ524917A (en) 2005-01-28
HUP0301178A2 (hu) 2003-11-28
AR030816A1 (es) 2003-09-03
UA73606C2 (en) 2005-08-15
PL362177A1 (en) 2004-10-18
JPWO2002028872A1 (ja) 2004-02-12
SI1329456T1 (sl) 2006-12-31
MXPA03002779A (es) 2004-05-04
IL155071A (en) 2010-04-15
CN1466590A (zh) 2004-01-07
DK1329456T3 (da) 2006-12-04
CA2423568C (en) 2011-03-15
BG66015B1 (bg) 2010-10-29
SK287811B6 (sk) 2011-10-04
ATE335753T1 (de) 2006-09-15
CA2423568A1 (en) 2002-04-11
US20040018998A1 (en) 2004-01-29
MY129023A (en) 2007-03-30

Similar Documents

Publication Publication Date Title
BR0114310A (pt) Derivados do glicopiranosiloxibenzilbenzeno e composições medicinais contendo os mesmos
BR0214343A (pt) Inibidores de 11 - beta - hidroxi esteróide desidrogenase tipo 1
AR032065A1 (es) Derivados de glucopiranosiloxipirazol y composicion farmaceutica
EP1609798A4 (en) CONDENSED HETEROCYCLIC DERIVATIVE, MEDICAL COMPOSITION, AND MEDICAL USE THEREOF
PT1213296E (pt) Derivados de glucopiranosiloxipirazole composicoes medicas que os contem e intermediarios na sua producao
NO20042161L (no) Inhibitorer av 11-beta-hydroksysteroid dehydrogenase type 1
AR023401A1 (es) Derivados de 1,4-benzotiazepina-1,1-dioxido sustituidos con restos de azucar, procedimientos para su preparacion, medicamentos que contienen estoscompuestos, y su empleo para preparar un medicamento
AR020662A1 (es) Compuestos dihidrotiazoles policiclicos, procedimientos para su preparacion, medicamento, procedimiento para la preparacion de dicho medicamento y lautilizacion de dichos compuestos para la preparacion de un medicamento.
BR0112589A (pt) Derivados de heteroarila e sua aplicação como medicamento
BR0210711A (pt) Uso de um composto, composição farmacêutica, composto, e, processo para a preparação de um composto
BRPI0509172A (pt) pelo menos uma entidade quìmica, composição farmacêutica, métodos para tratar um paciente, para inibir pelo menos uma enzima que utiliza atp, e para tratar pelo menos uma doença, uso de pelo menos uma entidade quìmica, e, método para a fabricação de um medicamento
BR0015188A (pt) Composições farmacêuticas
BR0207726A (pt) Sais farmacêuticos
BR0112591A (pt) Derivados de acridina e sua aplicação como medicamento
BR0313290A (pt) Derivado de pirazol, composição medicinal contendo o mesmo, uso medicinal dele, e intermediário para a sua produção
BR0209129A (pt) Compostos, composições farmacêuticas, métodos para tratamento de dores, métodos para modulação de uma resposta farmacológica e usos de compostos
CY1107939T1 (el) Συνεργικοι φαρμακευτικοι συνδυασμοι για την προληψη ή την αγωγη του διαβητη
UA83057C2 (ru) Замещенные производные диоксида тиазолбензоизотиазола и их применение
BR0012970A (pt) Compostos e composições antipicornavirais, seus usos farmacêuticos e materiais para a sua sìntese
WO2002042271A3 (en) Biphenylcarboxamides useful as lipid lowering agents
JO2390B1 (en) Diphenylcarboxamides act as lipid-lowering agents
PT1157015E (pt) Utilizacao de sistemas 2-amino-triazole policiclicos para a preparacao de medicamentos para tratamento de perturbacoes lipometabolicas, da obesidade e da diabetes tipo ii
ATE370156T1 (de) Makrolide
TW200510379A (en) 1, 4-disubstituted piperidine compounds, their preparation and use as medicaments
TW200503672A (en) 2-aminobenzoyl derivatives

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements